Brief: Mindmaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
26/05/2026 05:51
May 26 (Reuters) - MindMaze Therapeutics Holding SA MMTX.S: MINDMAZE THERAPEUTICS ANNOUNCES CHF 8.0 MILLION STRATEGIC EQUITY FINANCING MINDMAZE - AGREEMENT FOR CHF 8.0 MILLION EQUITY FINANCING WITH NEURO.IO GROUP , THROUGH WHICH NEURO.IO WILL ACQUIRE A STRATEGIC EQUITY POSITION IN COMPANY Source text: ID:nEQbfd3yxa Further company coverage: MMTX.S ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MindMaze Therapeutics Holding SA
See all newsBrief: Mindmaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
Brief: Relief Therapeutics Shareholders Approve Business Combination With Neurox
Brief: Relief Therapeutics Receives FDA Response To Qidp Request For Rlf-Td011
Brief: Relief Therapeutics Says Interim CEO Michelle Lock Has Completed Her Transitional Mandate
Swiss stocks - Factors to watch on May 13